1. Home
  2. LKFN vs TYRA Comparison

LKFN vs TYRA Comparison

Compare LKFN & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

N/A

Current Price

$60.30

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

N/A

Current Price

$23.00

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LKFN
TYRA
Founded
1872
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
LKFN
TYRA
Price
$60.30
$23.00
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$67.00
$32.17
AVG Volume (30 Days)
157.8K
576.3K
Earning Date
01-23-2026
11-05-2025
Dividend Yield
3.34%
N/A
EPS Growth
N/A
N/A
EPS
3.79
N/A
Revenue
$248,271,000.00
N/A
Revenue This Year
$17.16
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$15.81
N/A
Revenue Growth
2.85
N/A
52 Week Low
$50.00
$6.42
52 Week High
$73.85
$24.05

Technical Indicators

Market Signals
Indicator
LKFN
TYRA
Relative Strength Index (RSI) 57.46 68.10
Support Level $59.00 $21.65
Resistance Level $60.56 $23.74
Average True Range (ATR) 1.33 1.29
MACD 0.27 -0.12
Stochastic Oscillator 87.73 72.96

Price Performance

Historical Comparison
LKFN
TYRA

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: